Additionally, the experiments CH5183284 clinical trial indicated

that the toxin is the most active, or best activated, when first exposed to a short 10 min pulse at 47°C and then continuously incubated at 42°C for 120 hrs. The detection of the 2281 m/z (NT) and 1762 m/z (CT) product ions in each experiment confirmed that the lots of commercial toxin used were active. Relative quantification of type G toxin and NAPs was determined by use of MSE Label-free relative protein quantification was obtained for each component of the type G toxin complex (Table 2). When calculated by weight, the BoNT/G complex contained 30% of toxin, 38% of NTNH, 28% of HA70, and 4% of HA17. These percentages and nanogram amounts indicate that the overall weight ratio of BoNT:NAPs present within the complex is 1:3. The percentages of each molecule present in the complex are as follows: 17.2% of toxin, 23.1% of NTNH, 42.0% HA70, and 17.8% HA17. These percentages and femtomole

amounts indicate a 1:1:2:1 BoNT:NTNH:HA70:HA17 ratio, or a 1:4 BoNT:NAPs ratio, of molecules within the complex. Table 2 Relative quantification of Type G toxin and NAPs. Protein Description Accession # Avg Mass (kDa) Amount OnColumn % in the Complex       femtomoles nanograms molecules weight BoNT/G CAA52275 149034 110.0 16.4 17.2 30.4 NTNH type G CAA61228 139083 147.6 20.5 23.1 38.1 HA-70 (III) type G CAA61225 55791 268.5 BMS-907351 price 14.9 42.0 27.8 HA-17 (II) type G CAA61226 17372 113.8 1.9 17.8 3.7 The proteins identified in the/G complex, NCBI accession numbers, and average masses are shown, in addition to the calculated amounts on column, femtomoles and nanograms, and the percent Nintedanib (BIBF 1120) of each

protein, by weight and molarity, within the BoNT complex. Discussion BoNT/G is the least-studied and the most recently reported of the seven serotypes produced by C. botulinum. Although BoNT/G is associated with a distinct species and metabolic group, the toxin shares multiple characteristics with the other six progenitor toxins. The seven serotypes have similar biochemical and molecular mechanisms of cell entry and https://www.selleckchem.com/p38-MAPK.html membrane translocation. They cause disease by inhibiting synaptic transmission as a result of the enzymatic cleavage of the SNARE protein complex. In the present work, we detail the in silico comparison of BoNT/G progenitor toxin proteins to the other six serotypes of C. botulinum, as well as methods for the digestion, detection, and relative quantification of BoNT/G and its NAPs. The comparison of the BoNT/G progenitor toxin with the other six serotypes was completed to determine/G’s phenotypic relationship with the other BoNTs. In general, past analyses [7, 10, 23] have included a comparison at the gene level; this study focuses solely on protein level.